BPM31510 IV has recently received Rare Pediatric Disease designation from the U.S. Food and Drug Administration (FDA) for its potential as a treatment for Primary CoQ10 Deficiency (PCQD ...

BPM31510 IV has recently received Rare Pediatric Disease designation from the U.S. Food and Drug Administration (FDA) for its potential as a treatment for Primary CoQ10 Deficiency (PCQD) in addition ...

Taking an iron supplement can help prevent iron deficiency and improve your overall energy levels. It can also give you that soft baby skin you’ve always admired. CoQ10 is a naturally occurring ...

its investigational treatment for primary coenzyme Q10 (CoQ10) deficiency. This marks the first time a treatment for primary CoQ10 deficiency has received this designation, positioning BPGbio at the ...

Primary CoQ10 deficiency is a rare mitochondrial disorder that impacts fewer than one in 100,000 individuals. Credit: StudioMolekuul via Shutterstock. BPGbio has received a Rare Pediatric Disease ...

BPGbio has received a Rare Pediatric Disease Designation from the US Food and Drug Administration (FDA) for BPM31510IV to treat primary coenzyme Q10 deficiency, an ultra-rare mitochondrial disorder.

Clarkand Company/Getty Images Iron deficiency is linked to poorer brain health, heart failure, and other health concerns. A new study shows nearly 1 in 3 adults in the United States are deficient ...

Company is planning a potential pivotal trial of BPM31510IV targeting multiple CoQ10 deficiency mutations at multiple US and EU sites BOSTON, September 30, 2024--(BUSINESS WIRE)--BPGbio ...